These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies. Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061 [TBL] [Abstract][Full Text] [Related]
27. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133 [TBL] [Abstract][Full Text] [Related]
28. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer. Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593 [TBL] [Abstract][Full Text] [Related]
29. The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy. Perrin A; Venderink W; Patak MA; Möckel C; Fehr JL; Jichlinski P; Porcellini B; Lucca I; Futterer J; Valerio M Urol Oncol; 2021 May; 39(5):297.e9-297.e16. PubMed ID: 33341358 [TBL] [Abstract][Full Text] [Related]
30. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer]. Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051 [TBL] [Abstract][Full Text] [Related]
31. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694 [TBL] [Abstract][Full Text] [Related]
32. Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy. Fasciano D; Eich ML; Del Carmen Rodriguez Pena M; Rais-Bahrami S; Gordetsky J Int J Surg Pathol; 2020 Feb; 28(1):44-50. PubMed ID: 31342804 [TBL] [Abstract][Full Text] [Related]
33. Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital. Donato P; Morton A; Yaxley J; Teloken PE; Coughlin G; Esler R; Dunglison N; Gardiner RA; Roberts MJ World J Urol; 2020 Feb; 38(2):371-379. PubMed ID: 31055625 [TBL] [Abstract][Full Text] [Related]
34. [Diagnostic significance of multiparametric MRI combined with US-fusion guided biopsy of the prostate in patients with increased PSA levels and negative standard biopsy results to detect significant prostate cancer - Correlation with the Gleason score. Korrelation mit dem Gleason Score]. Hoffmann MA; Wieler HJ; Jakobs FM; Taymoorian K; Gerhards A; Miederer M; Schreckenberger M Nuklearmedizin; 2017 Aug; 56(4):147-155. PubMed ID: 28715042 [TBL] [Abstract][Full Text] [Related]
35. Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate. Maxeiner A; Kittner B; Blobel C; Wiemer L; Hofbauer SL; Fischer T; Asbach P; Haas M; Penzkofer T; Fuller F; Miller K; Cash H BJU Int; 2018 Aug; 122(2):211-218. PubMed ID: 29569320 [TBL] [Abstract][Full Text] [Related]
36. Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusion. Ecke TH; Schwaiger D; Nesterov G; Koswig S; Selinski S; Barrett T; Gnanapragasam V; Koch S; Hallmann S Urol Oncol; 2021 Nov; 39(11):781.e1-781.e7. PubMed ID: 33563540 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer. Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846 [TBL] [Abstract][Full Text] [Related]
38. Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling. Chelluri R; Kilchevsky A; George AK; Sidana A; Frye TP; Su D; Fascelli M; Ho R; Abboud SF; Turkbey B; Merino MJ; Choyke PL; Wood BJ; Pinto PA J Urol; 2016 Jul; 196(1):62-7. PubMed ID: 26880408 [TBL] [Abstract][Full Text] [Related]
39. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies. Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153 [TBL] [Abstract][Full Text] [Related]
40. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]